Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-05-07T09:22:19.406Z Has data issue: false hasContentIssue false
  • English
  • Français

STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN

Published online by Cambridge University Press:  15 August 2016

Bahareh Yazdizadeh ,
Safoura Shahmoradi ,
Reza Majdzadeh ,
Shila Doaee ,
Mohammad Bazyar ,
Aghdas Souresrafil  and
Alireza Olyaeemanesh
Bahareh Yazdizadeh
Affiliation:
Knowledge Utilization Research Centre (KURC), Tehran University of Medical Sciences (TUMS), Tehran, Iranse_shahmoradi@yahoo.com
Safoura Shahmoradi
Affiliation:
Knowledge Utilization Research Centre (KURC), Tehran University of Medical Sciences (TUMS), Tehran, Iranse_shahmoradi@yahoo.com
Reza Majdzadeh
Affiliation:
Community Based Participatory Research Center, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
Shila Doaee
Affiliation:
Medical Ethics and Law Research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Mohammad Bazyar
Affiliation:
Department of Health Management and Economics, Tehran University of Medical Sciences (TUMS), Tehran, Iran
Aghdas Souresrafil
Affiliation:
Tehran University of Medical Sciences, Tehran, Iran
Alireza Olyaeemanesh
Affiliation:
National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: This study was carried out to evaluate the opinions of stakeholders on their roles in health technology assessment (HTA) in Iran and to determine the barriers and facilitators existing in the organizations to help increase their involvement in the HTA program.

Methods: The study was conducted in two stages, semi-structured interviews, and “policy dialogue” with stakeholders. The data were analyzed through the framework approach.

Results: The interviews were held with ten stakeholder representatives from various organizations. In addition, Twenty-one representatives participated in the policy dialogue. Based on the findings, all the stakeholder organizations considered themselves as interest groups in all the stages of the HTA process; however, their tendencies and methods of involvement differed from one another. According to the participants, the most important issue to be considered in the context of HTA was that the structures, stages, and procedures of the HTA process must be made transparent.

Conclusions: Stakeholder involvement in the HTA program cannot readily take place. Various stakeholders have different interests, responsibilities, infrastructures, and barriers. If a program does not meet these considerations, its chances of succeeding will substantially decrease. Therefore, to prevent overlooking the needs and expectations of stakeholders from the HTA process, it is essential to create opportunities in which their thoughts and ideas are taken into account.

Keywords

HTAIranStakeholder involvementorganizing HTAHTA at National Level
Type
Policies
Information
International Journal of Technology Assessment in Health Care , Volume 32 , Issue 3 , 2016 , pp. 181 - 189
Copyright
Copyright © Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Oortwijn, W, Mathijssen, J, Banta, D. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries. Health Policy. 2010;95:174-184.CrossRefGoogle ScholarPubMed
2. Facey, K. Health Technology Assessment (HTA) glossary. Alberta, Canada: INAHTA; 2006.Google Scholar
3. OECD. The OECD Health Project: Health technology and decision making. Paris Organisation for Economic Co-operation and Development (OECD); 2005 http://www.oecd-ilibrary.org/ (accessed September 13, 2010).Google Scholar
4. Nielsen, CP, Lauritsen, SW, Kristensen, FB, et al. Involving stakeholders and developing a policy for stakeholder involvement in the European network for health technology assessment, EUnetHTA. Int J Technol Assess. 2009;25(Suppl 2):84-91.CrossRefGoogle ScholarPubMed
5. EUnetHTA Work Package 8. EUnetHTA Handbook on Health Technology Assessment Capacity Building. Barcelona, Spain: Catalan Agency for Health Technology Assessment and Research; 2008.Google Scholar
6. Doaee, S, Olyaeemanesh, A, Emami, S, et al. Development and implementation of health technology assessment: A policy study. Iran J Public Health. 2013;42(Suppl 1):50-54.Google ScholarPubMed
7. Doaee, S, Oliyaeemanesh, A, Nejati, M, et al. Establishment of health technology assessment in Iran. J Fam Reprod Health. 2012;6.Google Scholar
8. Ministry of Health and Medical Education (MOHME). The General Health Policies in Islamic Republic of Iran. 2014. http://www.behdasht.gov.ir/?siteid=1&siteid=1&pageid=1508&newsview=105234 (accessed on: 2014 June 15, 2014).Google Scholar
9. The Health Policy Council (HPC) of Ministry of Health and Medical Education (MOHME). The roadmap for health sector reform. Tehran: MOHME; 2012 [In Persian].Google Scholar
10. Pinson, N, Thielke, A, King, V. Health technology assessment (rapid review). Medicaid Evidence-based Decisions Project (MED). Portland; Oregon Health & Science University; 2011.Google Scholar
11. Hailey, DM. Health technology assessment in Canada: Diversity and evolution. Med J Aust. 2007;187:286.CrossRefGoogle ScholarPubMed
12. Healy, P, Pugatch, M. Theory versus practice: Discussing the governance of health technology assessment systems. Stockholm: Stockholm Network; 2009.Google Scholar
13. McDaid, D. Co-ordinating health technology assessment in Canada: A European perspective. Health Policy. 2003;63:205-213.CrossRefGoogle Scholar
14. Menon, D. Health technology assessment in Canada: A ten year review. Part 2. Edmonton, Canada: Institute of Health Economics Working Paper 00-5. 2000.Google Scholar
15. Department of Health and Ageing. Health technology assessment. 2011. Updated June 16, 2012. http://www.health.gov.au/hta (accessed July 10, 2012).Google Scholar
16. NIHR. Health Technology Assessment (HTA) Programme. 2014. http://www.nets.nihr.ac.uk/programmes/hta (accessed September 20, 2014).Google Scholar
17. Banta, D, Almeida, R. The development of health technology assessment in Brazil. Int J Technol Assess Health Care. 2009;25(Suppl 1):255-259.CrossRefGoogle ScholarPubMed
18. Ferraz, M, Soárez, P, Zucchi, P. Health technology assessment in Brazil: What do healthcare system players think about it? Sao Paulo Med J. 2011;129:198-205.CrossRefGoogle ScholarPubMed
19. Pope, C, Mays, N. Qualitative methods in health research, in qualitative research in health care. 3rd ed. Oxford, UK: Blackwell Publishing Ltd; 2006.CrossRefGoogle Scholar
20. Gauvin, F-P, Abelson, J, Giacomini, M, Eyles, J, Lavis, JN. “It all depends”: Conceptualizing public involvement in the context of health technology assessment agencies. Soc Sci Med. 2010;70:1518-1526.CrossRefGoogle ScholarPubMed
21. Frels, RK, Onwuegbuzie, AJ. Interviewing the interpretive researcher: An impressionist tale. Qual Report. 2012;17:1-27.Google Scholar
22. NIHR. National Institute for Health Research (NIHR). Tehran. 2014. [cited August 20, 2014] nihr.tums.ac.ir [In Persian].Google Scholar
23. Department of Health and Ageing in Australia. Stakeholder consultation. 2011 http://www.health.gov.au/internet/hta/publishing.nsf/Content/review-1#stakeholder (accessed April 20, 2015).Google Scholar
24. NICE. Developing technology appraisal guidance: A factsheet for patient and carer groups. London: NICE; 2014.Google Scholar
25. EUnetHTA. EUnetHTA JA Stakeholder involvement policy. 2010 http://www.eunethta.eu/outputs/eunethta-ja-stakeholder-involvement-policy (accessed April 25, 2015).Google Scholar
Supplementary material: File

Yazdizadeh supplementary material S1

Supplementary Figure

Download Yazdizadeh supplementary material S1(File)
File 67.1 KB
Supplementary material: File

Yazdizadeh supplementary material S2

Supplementary Table

Download Yazdizadeh supplementary material S2(File)
File 48.1 KB